ARTICLES BY THIS AUTHOR
- 4/4/2021
Supernus receives FDA OK for Qelbree
Supernus' Qelbree offers a novel once a day sprinkleable non-stimulant for children and adolescents with ADHD. - 4/4/2021
Blink Health taps David Chism as VP of pharmacy partnerships
Chism will be responsible for actively managing and growing Blink’s partnerships with the nation’s retailers. - 4/4/2021
Amneal acquires Kashiv Specialty Pharmaceuticals
Through the acquisition of Kashiv Specialty Pharmaceuticals, Amneal has gained a pipeline of 505(b)2 branded products and complex generics. - 4/4/2021
APhA launches rebranding effort
The American Pharmacists Association is rolling out a new brand identity, including a modernized website, redesigned logo and refined mission statement. - 4/4/2021
CVS Health unveils COVID-19 antibody testing at MinuteClinic locations across the nation
CVS Health is offering COVID-19 antibody testing at MinuteClinic locations, with results available within 15 minutes. - 4/1/2021
Walgreens, John Legend highlight importance of COVID-19 vaccines
Walgreens is rolling out the “This is Our Shot” campaign, featuring John Legend, to encourage COVID-19 vaccination, as well as address vaccine hesitancy. - 4/1/2021
Manrex purchases RxMedic's RM1 Pill Counting Technology
Manrex said it intends to expand RxMedic’s Table-Top Pill Counter's market presence in U.S. pharmacies. - 4/1/2021
Sanofi’s Sarclisa receives FDA nod for new indication
Sarclisa now is included in two standard of care regimens for the treatment of patients with multiple myeloma, as early as first relapse. - 4/1/2021
FDA gives tentative nod to Zydus Cadila's generic Truvada
Zydus Cadila's generic Truvada obtained the FDA's tentative approval in three dosage strengths. - 4/1/2021
Walmart expands COVID-19 vaccines to 48 states, Puerto Rico and Washington, D.C.
Walmart is administering vaccines in more than 3,800 stores and clubs across 48 states, including Puerto Rico and Washington, D.C.